{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:47:26Z","timestamp":1773798446707,"version":"3.50.1"},"reference-count":55,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>A method of rapidly pointing out the risk of developing persistent pulmonary fibrosis from a sample of blood is extraordinarily needed for diagnosis, prediction of death, and post-infection prognosis assessment. Collagen scar formation has been found to play an important role in the lung remodeling following SARS-CoV-2 infection. For this reason, the concentration of collagen degradation products in plasma may reflect the process of lung remodeling and determine the extent of fibrosis. According to our previously published results of an in vitro study, an increase in the concentration of type III collagen degradation products in plasma resulted in a decrease in the fluorescence lifetime of plasma at a wavelength of 450 nm. The aim of this study was to use time-resolved fluorescence spectroscopy to assess pulmonary fibrosis, and to find out if the lifetime of plasma fluorescence is shortened in patients with COVID-19. The presented study is thus far the only one to explore the fluorescence lifetime of plasma in patients with COVID-19 and pulmonary fibrosis. The time-resolved spectrometer Life Spec II with the sub-nanosecond pulsed 360 nm EPLED\u00ae diode was used in order to measure the fluorescence lifetime of plasma. The survival analysis showed that COVID-19 mortality was associated with a decreased mean fluorescence lifetime of plasma. The AUC of mean fluorescence lifetime in predicting death was 0.853 (95% CI 0.735\u20130.972, p &lt; 0.001) with a cut-off value of 7 ns, and with 62% sensitivity and 100% specificity. We observed a significant decrease in the mean fluorescence lifetime in COVID-19 non-survivors (p &lt; 0.001), in bacterial pneumonia patients without COVID-19 (p &lt; 0.001), and in patients diagnosed with idiopathic pulmonary fibrosis (p &lt; 0.001), relative to healthy subjects. Furthermore, these results suggest that the development of pulmonary fibrosis may be a real and serious problem in former COVID-19 patients in the future. A reduction in the mean fluorescence lifetime of plasma was observed in many patients 6 months after discharge. On the basis of these data, it can be concluded that a decrease in the mean fluorescence lifetime of plasma at 450 nm may be a risk factor for mortality, and probably also for pulmonary fibrosis in hospitalized COVID-19 patients.<\/jats:p>","DOI":"10.3390\/jcm11175081","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:13:56Z","timestamp":1661904836000},"page":"5081","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Mortality Risk and Pulmonary Fibrosis Investigated by Time-Resolved Fluorescence Spectroscopy from Plasma in COVID-19 Patients"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4667-6180","authenticated-orcid":false,"given":"Tomasz","family":"Wybranowski","sequence":"first","affiliation":[{"name":"Biophysics Department, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-067 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8981-3590","authenticated-orcid":false,"given":"Jerzy","family":"Pyskir","sequence":"additional","affiliation":[{"name":"Biophysics Department, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-067 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2254-0273","authenticated-orcid":false,"given":"Maciej","family":"Bosek","sequence":"additional","affiliation":[{"name":"Biophysics Department, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-067 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5397-8614","authenticated-orcid":false,"given":"Marta","family":"Napi\u00f3rkowska","sequence":"additional","affiliation":[{"name":"Biophysics Department, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-067 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5981-4461","authenticated-orcid":false,"given":"Micha\u0142","family":"Cyrankiewicz","sequence":"additional","affiliation":[{"name":"Biophysics Department, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-067 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0543-1163","authenticated-orcid":false,"given":"Blanka","family":"Ziomkowska","sequence":"additional","affiliation":[{"name":"Biophysics Department, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-067 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Pilaczy\u0144ska-Cemel","sequence":"additional","affiliation":[{"name":"Department of Lung Diseases, Neoplasms and Tuberculosis, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-067 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4305-7950","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Pyskir","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Faculty of Health Sciences, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-067 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Roga\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Lung Diseases, Neoplasms and Tuberculosis, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-067 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8050-6946","authenticated-orcid":false,"given":"Stefan","family":"Kruszewski","sequence":"additional","affiliation":[{"name":"Biophysics Department, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-067 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8324-163X","authenticated-orcid":false,"given":"Grzegorz","family":"Przybylski","sequence":"additional","affiliation":[{"name":"Department of Lung Diseases, Neoplasms and Tuberculosis, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85-067 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"ref_1","unstructured":"WHO (2020). Coronavirus Disease 2019 (COVID-19) Situation Report-98, World Health Organization. Available online: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200427-sitrep-98-covid-19.pdf?sfvrsn=90323472_4."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S0140-6736(20)30305-6","article-title":"Reducing mortality from 2019-nCoV: Host-directed therapies should be an option","volume":"395","author":"Zumla","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: Pathogenesis, etiology and regulation","volume":"2","author":"Wilson","year":"2009","journal-title":"Mucosal Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1378\/chest.09-0510","article-title":"New Mechanisms of Pulmonary Fibrosis","volume":"136","author":"Strieter","year":"2009","journal-title":"Chest"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1055\/s-0028-1101277","article-title":"Exposures and Idiopathic Lung Disease","volume":"29","author":"Taskar","year":"2008","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jmv.25709","article-title":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV","volume":"92","author":"Liu","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent Symptoms in Patients after Acute COVID-19","volume":"324","author":"Bernabei","year":"2020","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2213-2600(18)30502-2","article-title":"Lung transplantation for idiopathic pulmonary fibrosis","volume":"7","author":"George","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"L257","DOI":"10.1152\/ajplung.00238.2020","article-title":"Healing after COVID-19: Are survivors at risk for pulmonary fibrosis?","volume":"320","author":"McDonald","year":"2021","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1038\/s41379-020-00661-1","article-title":"COVID-19 pulmonary pathology: A multi-institutional autopsy cohort from Italy and New York City","volume":"33","author":"Borczuk","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"00346","DOI":"10.1183\/23120541.00346-2021","article-title":"Radiological\u2013pathological signatures of patients with COVID-19-related pneumomediastinum: Is there a role for the Sonic hedgehog and Wnt5a pathways?","volume":"7","author":"Baratella","year":"2021","journal-title":"ERJ Open Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Simioli, F., Annunziata, A., Polistina, G.E., Coppola, A., di Spirito, V., and Fiorentino, G. (2021). The Role of High Flow Nasal Cannula in COVID-19 Associated Pneumomediastinum and Pneumothorax. Healthcare, 9.","DOI":"10.3390\/healthcare9060620"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus\u2013Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijid.2020.10.067","article-title":"Asymptomatic hypoxia in COVID-19 is associated with poor outcome","volume":"102","author":"Brouqui","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12931-020-01516-8","article-title":"COVID-19 multidisciplinary high dependency unit: The Milan model","volume":"21","author":"Aliberti","year":"2020","journal-title":"Respir. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"E177","DOI":"10.1148\/radiol.2021203153","article-title":"Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia","volume":"299","author":"Han","year":"2021","journal-title":"Radiology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-2600(15)00048-X","article-title":"Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: An analysis from the prospective, multicentre PROFILE study","volume":"3","author":"Jenkins","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1183\/09031936.00024711","article-title":"Metalloproteinases in idiopathic pulmonary fibrosis","volume":"38","author":"Dancer","year":"2011","journal-title":"Eur. Respir. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12931-019-1118-7","article-title":"Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort","volume":"20","author":"Organ","year":"2019","journal-title":"Respir. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1002\/bit.27933","article-title":"Autofluorescence of blood and its application in biomedical and clinical research","volume":"118","author":"Shrirao","year":"2021","journal-title":"Biotechnol. Bioeng."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1021\/cr900343z","article-title":"Fluorescence Lifetime Measurements and Biological Imaging","volume":"110","author":"Berezin","year":"2010","journal-title":"Chem. Rev."},{"key":"ref_25","unstructured":"O\u2019Connor, D.V., and Phillips, D. (1984). Time-Correlated Single Photon Counting, Academic Press."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0959-440X(96)80030-3","article-title":"Time-resolved fluorescence spectroscopy","volume":"6","author":"Millar","year":"1996","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"051039","DOI":"10.1117\/1.JBO.20.5.051039","article-title":"Use of time-resolved fluorescence spectroscopy to evaluate diagnostic value of collagen degradation products","volume":"20","author":"Sikora","year":"2015","journal-title":"J. Biomed. Opt."},{"key":"ref_28","first-page":"20","article-title":"Fluorescence lifetime of collagen degradation products in plasma of patients with left ventricular remodeling","volume":"3","author":"Sikora","year":"2014","journal-title":"Med. Res. J."},{"key":"ref_29","unstructured":"WHO (2020). Clinical Management of Severe Acute Respiratory Infection  (SARI) When COVID-19 Disease Is Suspected: Interim Guidance, World Health Organization. Available online: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/clinical-management-of-novel-cov.pdf."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fcimb.2020.00340","article-title":"SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis","volume":"10","author":"Delpino","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/all.14364","article-title":"Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19","volume":"75","author":"Azkur","year":"2020","journal-title":"Allergy"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"118883","DOI":"10.1016\/j.lfs.2020.118883","article-title":"Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-\u03b2 signalling in COVID-19 survivors","volume":"266","author":"Sivashanmugam","year":"2021","journal-title":"Life Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/biof.1629","article-title":"Protective effect of rutin against bleomycin induced lung fibrosis: Involvement of TGF-\u03b21\/\u03b1-SMA\/\/Col I and III pathway","volume":"46","author":"Bai","year":"2020","journal-title":"BioFactors"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/17476348.2019.1623028","article-title":"Pulmonary fibrosis: A disease of alveolar collapse and collagen deposition","volume":"13","author":"Snijder","year":"2019","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41392-020-00355-9","article-title":"Pathological features of COVID-19-associated lung injury: A preliminary proteomics report based on clinical samples","volume":"5","author":"Leng","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1378\/chest.14-0397","article-title":"Matrix Metalloproteinases and Protein Tyrosine Kinases: Potential novel targets in acute lung injury and ARDS","volume":"146","author":"Aschner","year":"2014","journal-title":"Chest"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/01.CCM.0000048626.02184.F8","article-title":"Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients","volume":"31","author":"Lanchou","year":"2003","journal-title":"Crit. Care Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41598-021-04677-8","article-title":"Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients","volume":"12","author":"Gelzo","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"112067","DOI":"10.1016\/j.biopha.2021.112067","article-title":"MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients","volume":"142","author":"Couto","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"23205","DOI":"10.1038\/s41598-021-02547-x","article-title":"Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9","volume":"11","author":"Lerum","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e170721187996","DOI":"10.2174\/1871526520666201116100310","article-title":"Pharmacological Inhibition of MMP3 as a Potential Therapeutic Option for COVID-19 Associated Acute Respiratory Distress Syndrome","volume":"21","author":"Kadry","year":"2021","journal-title":"Infect. Disord. Drug Targets"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/jmv.26235","article-title":"Matrix metalloproteinase 3 as a valuable marker for patients with COVID-19","volume":"93","author":"Shi","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1007\/s00330-020-06969-5","article-title":"Association of \u201cinitial CT\u201d findings with mortality in older patients with coronavirus disease 2019 (COVID-19)","volume":"30","author":"Li","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ball, L., Barisione, E., Mastracci, L., Campora, M., Costa, D., Robba, C., Battaglini, D., Micali, M., Costantino, F., and Cittadini, G. (2021). Extension of Collagen Deposition in COVID-19 Post Mortem Lung Samples and Computed Tomography Analysis Findings. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147498"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12931-018-0779-y","article-title":"A Serological Biomarker of Versican Degradation is Associated with Mortality Following Acute Exacerbations of Idiopathic Interstitial Pneumonia","volume":"19","author":"Sand","year":"2018","journal-title":"Respir. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: The potential role for antifibrotic therapy","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jemermed.2020.04.004","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"58","author":"Eastin","year":"2020","journal-title":"J. Emerg. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41591-020-1132-9","article-title":"Modeling COVID-19 scenarios for the United States","volume":"27","author":"Reiner","year":"2021","journal-title":"Nat. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2003690","DOI":"10.1183\/13993003.03690-2020","article-title":"Pulmonary function and radiological features 4 months after COVID-19: First results from the national prospective observational Swiss COVID-19 lung study","volume":"57","author":"Guler","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Fabbri, L., Moss, S., Khan, F., Chi, W., Xia, J., Robinson, K., Smyth, A., Jenkins, G., and Stewart, I. (2021). Post-viral parenchymal lung disease of COVID-19 and viral pneumonitis: A systematic review and meta-analysis. medRxiv.","DOI":"10.1101\/2021.03.15.21253593"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/imr.12977","article-title":"COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts","volume":"302","author":"John","year":"2021","journal-title":"Immunol. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(21)00174-0","article-title":"3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study","volume":"9","author":"Wu","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: A clinical\u2013therapeutic staging proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J. Heart Lung Transplant."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/17\/5081\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:19:59Z","timestamp":1760141999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/17\/5081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":55,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["jcm11175081"],"URL":"https:\/\/doi.org\/10.3390\/jcm11175081","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]}}}